Protease production by Staphylococcus epidermidis and its effect on Staphylococcus aureus biofilms

Due to the resistance of Staphylococcus aureus to several antibiotics, treatment of S.aureus infections is often difficult. As an alternative to conventional antibiotics, the field of bacterial interference is investigated. Staphylococcus epidermidis produces a serine protease (Esp) which inhibits S.aureus biofilm formation and which degrades S.aureus biofilms. In this study, we investigated the protease production of 114 S.epidermidis isolates, obtained from biofilms on endotracheal tubes (ET). Most of the S.epidermidis isolates secreted a mixture of serine, cysteine and metalloproteases. We found a link between high protease production by S.epidermidis and the absence of S.aureus in ET biofilms obtained from the same patient. Treating S.aureus biofilms with the supernatant (SN) of the most active protease producing S.epidermidis isolates resulted in a significant biomass decrease compared to untreated controls, while the number of metabolically active cells was not affected. The effect on the biofilm biomass was mainly due to serine proteases. Staphylococcus aureus biofilms treated with the SN of protease producing S.epidermidis were thinner with almost no extracellular matrix. An increased survival of Caenorhabditis elegans, infected with S.aureus Mu50, was observed when the SN of protease positive S.epidermidis was added.